- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
RSNA 2021 Preview: Canon Medical Touts Advances Across Modalities
Learn more about what Canon Medical will be showcasing virtually at RSNA 2021.
RSNA 2021 is quickly approaching as members of the greater radiology healthcare community prepare to immerse themselves in five days of scientific sessions, key lectures, and exciting product demonstrations.
Diagnostic Imaging sat down with Canon Medical's David Hashimoto, Senior Director, Full Line BUs and Solutions Marketing, to learn more about what Canon has planned for their virtual participation in RSNA 2021.
Canon Medical will offer attendees--both in-person and virtual--an immersive experience that includes live product demonstrations and scheduled briefings with Canon Medical experts across the breadth of their portfolio, including CT, molecular imaging, MRI, ultrasound, X-ray, interventional radiology, and healthcare IT.
For the latest coverage of RSNA 2021, click here.
In addition, Canon Medical will also be hosting a roundtable discussion, "State of AI in Radiology Today," featuring a distinguished panel of speakers who will discuss the financial, technical, clinical, and regulatory considerations of applying AI in today's radiology practice and in the future.
Those interested in the roundtable discussion can pre-register here.
To learn more about what Canon Medical will be sharing at RSNA 2021, click here.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
